Gene delivery with polycationic fullerene hexakis-adducts by Sigwalt, David (David Sigwalt (dsigwalt@unistra.fr)) (author) et al.
This journal is c The Royal Society of Chemistry 2011 Chem. Commun.
Cite this: DOI: 10.1039/c0cc05783e
Gene delivery with polycationic fullerene hexakis-adductsw
David Sigwalt,ab Michel Holler,a Julien Iehl,a Jean-Franc¸ois Nierengarten,*a Marc Nothisen,b
Emmanuelle Morinb and Jean-Serge Remy*b
Received 24th December 2010, Accepted 25th January 2011
DOI: 10.1039/c0cc05783e
Polyplexes prepared from DNA and globular compact polycationic
derivatives constructed around a fullerene hexakis-adduct core
have shown remarkable gene delivery capabilities.
Carbon rich nanostructures have been a major hot topic in
chemical research over the past two decades.1 In particular,
fullerenes combining three-dimensionality with unique electronic
properties are extremely promising nanostructures for the
preparation of new advanced materials2 or biologically active
molecules.3 Whereas materials science applications of fullerenes
have focused an enormous attention, medicinal chemistry of
fullerenes has been somehow limited by the absence of solu-
bility of most fullerene derivatives in aqueous media. Never-
theless, fullerenes had a significant impact in the field of
biology.3,4 In particular, Nakamura and co-workers have
shown that cationic fullerene derivatives exhibit a practically
useful level of transfection.5,6 Importantly, the cytotoxicity of
the fullerene derivatives is in general negligible both in the
presence and in the absence of ambient light, in spite of the
photoreactivity of fullerenes. In a systematic structure–activity
relationship investigation performed on a library of 22 fullerene
cationic derivatives, Nakamura and co-workers have also
shown that an appropriate hydrophobic–hydrophilic balance
appears to be essential to form fullerene–DNA nanostructures
capable of crossing the cell membrane and thus to release
DNA for gene expression.7 This study revealed in particular
that fullerene hexakis-adduct C60(NH3
+)12
8 (Fig. 1) is fully
inactive as a gene-delivery agent.7
The latter observation led to the generally admitted conclusion
that compact globular polycations with an isotropic distribu-
tion of positive charges are not suitable candidates for transfec-
tion studies.9 In this communication, we now show that this is
indeed not the case. Effectively, polyplexes prepared from
DNA and globular compact polycationic derivatives con-
structed around a fullerene hexakis-adduct core revealed
remarkable gene delivery capabilities. As in the case of
dendritic vectors for gene delivery,10 the efficiency is increased
by increasing the generation number of the system. However,
in contrast to classical dendritic vectors for which high
efficiency requires generally high generation numbers,11 the
compact hexasubstituted fullerene core led to globular systems
even with low-generation dendrons12 and thus the gene
delivery capability is already optimum for the second genera-
tion compound.
The synthesis of the polycationic fullerene hexa-adduct
derivatives G1-3NH3
+ is depicted in Scheme 1. The hexa-
substituted fullerene building block 1 was prepared in two
steps according to a reported procedure.13 Compounds G1-3N3
(Fig. 2) were obtained from the corresponding benzylic bromides
(NaN3, DMF) which were prepared by following the classical
route developed by Hawker and Fre´chet14 for the synthesis of
polybenzylether dendrons (see ESIw).
The grafting of azides G1-3N3 onto the hexa-substituted
fullerene core was achieved under the Cu-catalyzed alkyne-
azide 1,3-dipolar cycloaddition conditions.13 Treatment of 1 with
a slight excess of azides GnN3 (n = 1, 2 or 3; 13 equiv.) in the
presence of tetrabutylammonium fluoride (TBAF), CuSO4!5H2O
and sodium ascorbate in CH2Cl2/H2O gave the corresponding
benzyloxycarbonyl (Boc)-protected dendrimers GnNHBoc
(n = 1, 2 or 3) in remarkable isolated yields. It is worth noting
that the preparation of such fullerodendrimers would be
nearly impossible from C60 and the corresponding malonates
thus highlighting the advantages of the synthetic strategy
Fig. 1 Compound C60(NH3
+)12.
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based on the post-functionalization of a readily available
fullerene hexa-adduct under the Cu-mediated Huisgen reaction
conditions.13,15
The chemical structure of compounds G1-3NHBoc was
confirmed by 1H and 13C NMR, IR and UV/vis spectroscopies
as well as by elemental analyses. Their 13C NMR spectra were
particularly helpful to evidence their Th-symmetrical structure
(Fig. S1, ESIw). In all the cases, the 3 expected signals of the
hexa-substituted fullerene core are clearly observed (d = 69.2
for the sp3 C atom; 141.1–141.2 and 145.7–145.9 ppm for the
sp2 C atoms). The high symmetry of G1-3NHBoc was also
revealed by the equivalence of the 6 malonate addends. The
typical signals of the sp2 C atoms of the 12 newly formed
equivalent 1,2,3-triazole subunits are detected at d 121.6–121.8
and 146.7–147.1 ppm. Treatment of G1-3NHBoc with a large
excess of trifluoroacetic acid (TFA) gave the corresponding
deprotected derivatives G1-3NH3
+ as their trifluoroacetate
salts in quantitative yields. Inspection of the 1H and 13C NMR
spectra of G1-3NH3
+ clearly indicates the disappearance of
the Boc-protecting groups. Furthermore, the two typical
quartets corresponding to the two C atoms of the trifluoro-
acetate counteranions are observed in the 13C NMR spectra
of G1-3NH3
+ (Fig. S2, ESIw). IR data further confirmed
the disappearance of the Boc protecting groups (ca. 3350 and
1695 cm"1) and the presence of the trifluoroacetate counter-
anions (1671 cm"1, see Fig. S3–S5, ESIw). To further confirm
the structure of G1-3NH3
+, mass spectra (MALDI-TOF,
ESMS and FAB) were recorded under different conditions.
However, in all the cases, high level of fragmentation prevented
the observation of the expected molecular ion peak as in the
case of fullerene hexa-adducts substituted with peripheral
sugar residues.16
Electrostatic interactions between plasmid DNA and
G1-3NH3
+ were quantified by agarose gel electrophoresis
(gel shift) of polyplexes17 made with increasing N/P (vector
amine per DNA phosphate) ratios. Ethidium bromide fluores-
cence showed full DNA condensation at N/P 2, for all
derivatives, both in isotonic 150 mM NaCl and in iso-osmotic
5% glucose solutions in water (Fig. S6, ESIw). Polyplexes were
further characterized by Transmission Electron Microscopy
(TEM). When prepared in 5% glucose, polyplexes prepared at
N/P 3 and 5 showed spherical ‘donut-like’ structures, with
diameters smaller than 100 nm (Fig. 3 and Fig. S10, ESIw).
These results were confirmed by Dynamic Light Scattering
(DLS) (see ESIw). Zeta (B) potential measurements made
on the same polyplexes showed strongly positive surface
charges (Fig. S7–S9, ESIw). When prepared in 150 mM NaCl,
polyplexes become micrometric structures made of aggregated
Scheme 1 Reagents and conditions: (i) TBAF, sodium ascorbate,
CuSO4!5H2O cat., CH2Cl2/H2O (1 : 1), 25 1C [from G1N3 :G1NHBoc
(85%); from G2N3 :G2NHBoc (68%); from G3N3 :G3NHBoc (89%)];
(ii) CF3CO2H, 25 1C [from G1NHBoc :G1NH3
+ (quantitative);
from G2NHBoc :G2NH3
+ (quantitative); from G3NHBoc :G3NH3
+
(quantitative)].
Fig. 2 Azide precursors G1-3N3.
Fig. 3 TEM images of G2NH3
+/pCMVLuc polyplexes at N/P 3
(A) and G3NH3
+/pCMVLuc polyplexes at N/P 5 (B) in water with
5% glucose. The bars indicate 100 nm.
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spheres (Fig. S13–S15, ESIw), reminiscent of structures found
with polyethylenimine (PEI).18 Note that B potential in the
saline conditions could not be determined.
pCMV-Luc gene delivery experiments were conducted with
G1-3NH3
+ polyplexes on HeLa cells, prepared either in 5%
glucose (Fig. 4 and Fig. S16, ESIw) or 150 mM NaCl
(Fig. S17w) solution. In both cases, G2NH3+ and G3NH3+
had practically the same level of luciferase expression at their
optimal N/P ratio (i.e. between 1011 and 1012 RLU mg"1 of
protein) than that of a commercially available gene delivery
system, namely JetSIt-ENDO (Polyplus-Transfection),
known for its high efficiency/toxicity ratio. Moreover,
G3NH3
+ had little if not no toxicity at its optimal N/P
2 ratio.G1NH3
+ had no efficiency when prepared in isotonic solu-
tion and only showed a moderate efficiency (ca. 109 RLU mg"1
of protein, Fig. S16, ESIw), when prepared in iso-osmotic
solution. Strengthened by the fact that electrostatic inter-
actions are lowered in saline conditions, it seems clear that
G1NH3
+ only has a limited DNA condensation capacity, due
to its low number of protonable amino groups. This is also in
good agreement with the results obtained by Nakamura et al.
with C60(NH3
+)12.
7 Conversely, G2NH3
+ and G3NH3
+ have
enough amino groups to ensure DNA compaction into stable
and positively charged polyplexes, that fruitfully deliver DNA
into cells. What is more, these spherical polymers exhibit high
efficiency, while maintaining low toxicity.
In conclusion, polycationic fullerene hexakis-adducts are
efficient and non-toxic gene transfection vectors despite an
isotropic distribution of positive charges around a compact
globular structure. Owing to the possibility of functionalizing
hexasubstituted fullerenes with two or more different functional
groups,13,15d the results reported therein pave the way towards
the development of new vectors capable of carrying out several
tasks. Work in this direction is underway in our laboratories.
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